Literature DB >> 20547802

Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates.

Ronald N Jones, Mariana Castanheira, Michael A Pfaller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20547802      PMCID： PMC2935005          DOI： 10.1128/AAC.00330-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  16 in total

1.  Quality control parameters for broth microdilution tests of anidulafungin.

Authors:  Karen Krisher; Steven D Brown; Maria M Traczewski
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.

Authors:  M A Pfaller; D J Diekema; J H Rex; A Espinel-Ingroff; E M Johnson; D Andes; V Chaturvedi; M A Ghannoum; F C Odds; M G Rinaldi; D J Sheehan; P Troke; T J Walsh; D W Warnock
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

3.  Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.

Authors:  M A Pfaller; D J Diekema; L Ostrosky-Zeichner; J H Rex; B D Alexander; D Andes; S D Brown; V Chaturvedi; M A Ghannoum; C C Knapp; D J Sheehan; T J Walsh
Journal:  J Clin Microbiol       Date:  2008-06-25       Impact factor: 5.948

4.  Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis.

Authors:  Varsha Moudgal; Tania Little; Dina Boikov; Jose A Vazquez
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.

Authors:  Daniel J Diekema; Shawn A Messer; Richard J Hollis; Linda Boyken; Shailesh Tendolkar; Jennifer Kroeger; Ronald N Jones; Michael A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  2008-12-12       Impact factor: 2.803

6.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

7.  Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007).

Authors:  Shawn A Messer; Gary J Moet; Jeffrey T Kirby; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

8.  Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

Authors:  Luis Ostrosky-Zeichner; John H Rex; Peter G Pappas; Richard J Hamill; Robert A Larsen; Harold W Horowitz; William G Powderly; Newton Hyslop; Carol A Kauffman; John Cleary; Julie E Mangino; Jeannette Lee
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

9.  In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

Authors:  M A Pfaller; L Boyken; R J Hollis; J Kroeger; S A Messer; S Tendolkar; D J Diekema
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

Review 10.  Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.

Authors:  Susanne Perkhofer; Cornelia Lass-Flörl
Journal:  Expert Opin Investig Drugs       Date:  2009-09       Impact factor: 6.206
View more
  2 in total

1.  Multilaboratory testing of antifungal drug combinations against Candida species and Aspergillus fumigatus: utility of 100 percent inhibition as the endpoint.

Authors:  Ping Ren; Ming Luo; Shao Lin; Mahmoud A Ghannoum; Nancy Isham; Dan J Diekema; Michael A Pfaller; Shawn Messer; Shawn R Lockhart; Naureen Iqbal; Vishnu Chaturvedi
Journal:  Antimicrob Agents Chemother       Date:  2014-12-15       Impact factor: 5.191

2.  Novel method for evaluating in vitro activity of anidulafungin in combination with amphotericin B or azoles.

Authors:  R Teixeira-Santos; R Rocha; A Moreira-Rosário; M Monteiro-Soares; E Cantón; A G Rodrigues; C Pina-Vaz
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.